FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used in therapy. A method for evaluating the effectiveness of treating pneumonia by examining a general blood test before and after treatment is to additionally determine in the blood serum the amount of C-reactive protein, the activity of catalase, superoxide dismutase, elastase- and trypsin-like proteinases, the level of TBA-active compounds and the concentration of bityrosine and to calculate the discriminant functions of Y1 and Y2, and with Y1 greater than Y2 and a decrease in the number of leukocytes by 30% or more, the activity of trypsin-like proteinases by 20% or more, the number of eosinophils by 50% or more, as well as ESR by 50% or more, the amount of C-reactive protein by 50% or more, SOD activity by 50% or more, the level of TBA-active compounds by 50% or more, the concentration of bityrosine by 50% or more compared to the level before treatment, the treatment of pneumonia with alveolar type of infiltration in the lung tissue is evaluated as effective.
EFFECT: invention provides increased accuracy of evaluating effectiveness of treatment of pneumonia.
1 cl, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING COURSE OF PNEUMONIA WITH ALVEOLAR TYPE OF LUNG TISSUE INFILTRATION | 2020 |
|
RU2753745C1 |
METHOD FOR EVALUATING EFFECTIVENESS OF TREATMENT OF PNEUMONIA | 2020 |
|
RU2753746C1 |
DIAGNOSTIC METHOD OF COMATOSE STATE IN CASE OF PNEUMONIA | 2020 |
|
RU2738442C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF PULMONARY TISSUE INFILTRATION TYPE IN PNEUMONIA | 2020 |
|
RU2738450C1 |
METHOD FOR DETECTING MICROCIRCULATORY DISORDERS AS A BIOMARKER OF INTERSTITIAL CHANGES IN THE LUNGS OF PATIENTS UNDERGONE A NEW CORONAVIRUS INFECTION | 2022 |
|
RU2790513C1 |
METHOD FOR PREDICTING OUTCOME OF INFECTIOUS PROCESS AFTER A NEW CORONAVIRUS INFECTION FOR 12 MONTHS | 2023 |
|
RU2807384C1 |
METHOD FOR EARLY DIFFERENTIAL DIAGNOSIS OF VIRAL AND BACTERIAL COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN | 2022 |
|
RU2790239C1 |
METHOD FOR DIAGNOSING AUTOIMMUNE PATHOLOGY | 1999 |
|
RU2146371C1 |
METHOD OF PNEUMONIA TREATMENT | 1993 |
|
RU2070043C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF BENIGN, PRIMARY AND SECONDARY MALIGNANT BRAIN TUMORS | 2016 |
|
RU2628816C1 |
Authors
Dates
2021-08-23—Published
2020-06-16—Filed